HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SafetyCall On What Cosmetics Companies Need In Their AE Reporting Systems

Executive Summary

Companies preparing for adverse event reporting and recordkeeping deadlines on 29 December under new cosmetics regulations should ensure they have systems in place for netting complaints across media, triaging reports, and making speedy weight-of-evidence determinations, said SafetyCall International’s Rick Kingston at IBA’s recent FDA regulatory workshop.

You may also be interested in...



FDA Updates Instructions For Reporting Serious Adverse Events Under MoCRA

The US Food and Drug Administration simplifies instructions for filing reports on serious adverse events under the Modernization of Cosmetics Regulation Act; promotes soon-to-launch electronic-reporting platform.

Refillable Personal-Care Packaging: Experts Discuss Contamination Risks, Liability, MoCRA Compliance

Personal-care companies navigating a growing patchwork of state recycling laws are exploring refillable packaging options, but there are serious concerns and questions to consider before embarking down this potentially risky path, experts said at IBA’s Supply Chain & Sustainability Conference.

MoCRA Check-In: Tick, Tock, Tick, Tock…

The compliance clock is ticking! A breakdown of key requirements under new cosmetics regulations and related developments in recent weeks.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS154059

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel